GGrantIndex
Sort

51,593 grants matching hepatitis

Clinical Trial of CNS Penetrating ART to Prevent NeuroAIDS in China

$524,494
Scott L Letendre · University Of California, San Diego · R01 · FY2012 · MH

Control of Lipogenesis and Hepatic Steatosis by Caspase-2

$524,457
Michael Karin · University Of California, San Diego · R01 · FY2024 · DK

Mechanism of cold platelet clearance

$524,412
John H Hartwig · Immune Disease Institute, Inc. · P01 · FY2010 · HL

Kalamazoo Community Clinical Oncology Program

$524,412
Raymond S Lord · West Michigan Cancer Center · U10 · FY2012 · CA

Alcohol and Chronic Disease Among Vulnerable Populations

$524,395
Harvard University (Sch Of Public Hlth) · R01 · FY2005 · AA

Nuclear Envelope, Lipoprotein Metabolism, and Hepatic Steatosis

$524,393
Howard J Worman · Columbia University Health Sciences · R01 · FY2020 · DK

Nuclear Envelope, Lipoprotein Metabolism, and Hepatic Steatosis

$524,393
Howard J Worman · Columbia University Health Sciences · R01 · FY2021 · DK

Nuclear Envelope, Lipoprotein Metabolism, and Hepatic Steatosis

$524,391
Howard J Worman · Columbia University Health Sciences · R01 · FY2022 · DK

USC Cirrhosis Clinical Center

$524,271
Norah A. Terrault · University Of Southern California · U01 · FY2023 · DK

Yale Drug use, Addiction and HIV Research Scholars (DAHRS)

$523,901
Gail D'onofrio · Yale University · K12 · FY2020 · DA

Coactivator P300 promotes hepatic steatosis in obesity

$523,897
Ling He · Johns Hopkins University · R01 · FY2023 · DK

Developmental flame retardant exposure, gut microbiome, and obesity

$523,875
Julia Yue Cui · Oregon State University · R01 · FY2025 · ES

HCV-specific T cell response

$523,850
Christopher M. Walker · Research Inst Nationwide Children'S Hosp · R37 · FY2006 · AI

COMT Genotype and Risky Decision Making in HIV and Methamphetamine Dependence

$523,833
Mariana Cherner · University Of California, San Diego · R01 · FY2010 · DA

Notch, Type 2 Diabetes and NAFLD

$523,795
Utpal Pajvani · Columbia University Health Sciences · R01 · FY2022 · DK

Notch, Type 2 Diabetes and NAFLD

$523,795
Utpal Pajvani · Columbia University Health Sciences · R01 · FY2021 · DK

Notch, Type 2 Diabetes and NAFLD

$523,795
Utpal Pajvani · Columbia University Health Sciences · R01 · FY2023 · DK

Inflammation and hepatic lipid metabolism

$523,764
Alan R. Saltiel · University Of California, San Diego · R01 · FY2020 · DK

Training

$523,745
Patricia A Totten · Path · U54 · FY2010 · EB

Liver Parametric PET

$523,648
Guobao Wang · University Of California At Davis · R01 · FY2023 · DK

High throughput screening of orthosteric inhibitors of flavivirus protease

$523,552
Hongmin Li · Wadsworth Center · R56 · FY2017 · AI

Development of a Multiscale Mechanistic Simulation of Acetaminophen Induced Liver

$523,550
James Alexander Glazier · Trustees Of Indiana University · U01 · FY2015 · GM

NATURAL HISTORY OF HEPATITIS C INFECTION IN HIV DISEASE

$523,520
Boston Medical Center · R01 · FY2001 · DK

Studying alcohol-associated liver disease and its interaction with rs738409 variant in PNPLA3 in a liver culture model

$523,477
Xianfang Wu · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · AA

Studying alcohol-associated liver disease and its interaction with rs738409 variant in PNPLA3 in a liver culture model

$523,477
Xianfang Wu · Cleveland Clinic Lerner Com-Cwru · R01 · FY2024 · AA